Marizyme, Inc. (MRZM)
MRZM Stock Price Chart
Explore Marizyme, Inc. interactive price chart. Choose custom timeframes to analyze MRZM price movements and trends.
MRZM Company Profile
Discover essential business fundamentals and corporate details for Marizyme, Inc. (MRZM) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
10 Nov 2010
Employees
13.00
Website
https://marizyme.comCEO
David L. Barthel
Description
Marizyme, Inc., a life science company, engages in the development and commercialization of medical technologies business. It offers DuraGraft, a one-time intraoperative vascular graft treatment for use in vascular and bypass surgeries that maintains endothelial function and structure, and other related properties. The company also develops various products using its Krillase protease-based therapeutic platform for treating complex wounds and burns, acute ischemic stroke, deep vein thrombosis, and dissolving plaque and biofilms on teeth. In addition, it focuses on developing products to mitigate the effects of ischemia reperfusion injury in other grafting and transplantation surgeries, and other indications. Further, it is involved in developing MATLOC, a point-of-care, lab-on-chip digital screening and diagnostic device platform for chronic kidney disease assessment. The company was formerly known as GBS Enterprises Incorporated. Marizyme, Inc. was incorporated in 2007 and is based in Jupiter, Florida.
MRZM Financial Timeline
Browse a chronological timeline of Marizyme, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Mar 2026
Upcoming earnings on 5 Mar 2026
Earnings released on 4 Jun 2025
Earnings released on 15 May 2025
Earnings released on 7 Mar 2025
Earnings released on 15 Nov 2024
Earnings released on 14 Aug 2024
EPS came in at -$0.03 .
Earnings released on 28 May 2024
EPS came in at -$0.05 , while revenue for the quarter reached $32.86K .
Earnings released on 24 Mar 2024
EPS came in at -$0.15 , while revenue for the quarter reached $150.56K .
Earnings released on 14 Nov 2023
EPS came in at -$0.71 , while revenue for the quarter reached $181.54K .
Earnings released on 18 Aug 2023
EPS came in at -$0.48 , while revenue for the quarter reached $184.74K .
Earnings released on 15 May 2023
EPS came in at -$0.12 , while revenue for the quarter reached $128.97K .
Earnings released on 24 Mar 2023
EPS came in at -$0.02 , while revenue for the quarter reached $76.01K .
Earnings released on 31 Dec 2022
EPS came in at -$1.10 , while revenue for the quarter reached $95.66K .
Earnings released on 30 Jun 2022
EPS came in at -$0.23 , while revenue for the quarter reached $61.81K .
Earnings released on 31 Mar 2022
EPS came in at -$0.20 .
Earnings released on 31 Dec 2021
EPS came in at -$0.15 , while revenue for the quarter reached -$61.67K .
Earnings released on 30 Sept 2021
EPS came in at -$0.05 , while revenue for the quarter reached $37.22K .
Earnings released on 30 Jun 2021
EPS came in at -$0.07 , while revenue for the quarter reached $160.79K .
Earnings released on 31 Mar 2021
EPS came in at -$0.08 , while revenue for the quarter reached $73.95K .
Earnings released on 31 Dec 2020
EPS came in at -$0.10 , while revenue for the quarter reached $72.15K .
Earnings released on 30 Sept 2020
EPS came in at -$0.07 , while revenue for the quarter reached $124.99K .
MRZM Stock Performance
Access detailed MRZM performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.